Advertisement
Home 2015

Archives

The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA)

FDA: Device Authorized for Use in Dialysis-Related Amyloidosis

0
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
The U.S. Food and Drug Administration has approved Zarxio (filgrastim-sndz)

FDA Approves First Biosimilar Drug in U.S.

0
Zarxio is highly similar to long-sanctioned cancer drug
A mobile phone application has been released to identify current drug shortages

FDA Launches First App to Identify Drug Shortages

0
App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages
The Society of Thoracic Surgeons has released the first publicly accessible report of surgical outcomes from its Congenital Heart Surgery Database.

STS Releases Outcomes for Congenital Heart Sx Database

0
Society of Thoracic Surgeons has made data available for pediatric, congenital heart surgery
Rush University Medical Center's website has started adding the results of patient surveys to individual physician profiles

Rush University Adds Patient Scores to Doctor Profiles

0
Scores based on 30 or more patient surveys completed in one-year period
U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small-cell lung cancer

FDA: Opdivo Approval Expanded to Include Lung Cancer

0
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Resistance to commonly used antimicrobials is increasing in Salmonella and Campylobacter

Resistance to Common Antimicrobials Increasing

0
Salmonella, Campylobacter show significant resistance in humans and animals
An American nurse who contracted Ebola is suing her employer.

U.S. Nurse Who Contracted Ebola Sues Employer

0
Believes her Ebola infection was a direct result of a lack of training
According to a new report

ASPS: Cosmetic Procedures Increased 3 Percent in 2014

0
15.6 million cosmetic procedures performed in the United States in 2014
The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract

FDA Approves New Combination Antibiotic Avycaz

0
Combination drug sanctioned for abdominal, urinary tract infections